SCHEMBL6653355

SCHEMBL6653355

COc1cc(C(=O)c2ccccc2C)ccc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 4/20 0.54
▸ MAPK13 O15264 3/20 0.54
▸ MAPK12 P53778 3/20 0.54
▸ MAPK11 Q15759 3/20 0.54
▸ ALDH1A1 P00352 5/20 0.51
▸ HTT P42858 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ TUBB4A P04350 1/20 0.48
▸ TUBB P07437 1/20 0.48
▸ TUBA3C P0DPH7 1/20 0.48
▸ TUBA1B P68363 1/20 0.48
▸ TUBA4A P68366 1/20 0.48
▸ TUBB4B P68371 1/20 0.48
▸ TUBB3 Q13509 1/20 0.48
▸ TUBB2A Q13885 1/20 0.48
▸ TUBB8 Q3ZCM7 1/20 0.48
▸ TUBA3E Q6PEY2 1/20 0.48
▸ TUBA1A Q71U36 1/20 0.48
▸ TUBA1C Q9BQE3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7364817 0.84 SLC22A6 (0.68) ALDH1A1HTTLMNAL3MBTL1TUBB4A
SCHEMBL11810033 0.83 CYP1A2 (0.51) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL6651159 0.83 MAPK13 (0.65) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL436813 0.82 ALDH1A1 (0.72) ALDH1A1HTTLMNAL3MBTL1TUBB4A
SCHEMBL6659642 0.82 MAPK14 (0.76) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL4610035 0.81 CYP1A2 (0.62) ALDH1A1HTTLMNAL3MBTL1TUBB4A
SCHEMBL8622568 0.81 ALDH1A1 (0.70) ALDH1A1HTTLMNAL3MBTL1TUBB4A
SCHEMBL8625272 0.80 ALDH1A1 (0.64) ALDH1A1HTTLMNAL3MBTL1TUBB4A
SCHEMBL11814930 0.79 ALDH1A1 (0.55) ALDH1A1HTTLMNATSHRCYP1A2
SCHEMBL31331742 0.79 CYP1A2 (0.64) ALDH1A1HTTLMNAL3MBTL1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 — — EP disclosed
US-6313174-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGY, RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, GOUT, ATHEROSCLEROSIS, CHRONIC INFLAMMATORY BOWEL DISEASE, PROLIFERATIVE AND INFLAMMATORY SKIN DISORDERS Leo Pharmaceutical Products Ltd.A/S/ (Løvens kemiske Fabrik Produktionsaktieselskab) (DK) 2001-11-06 — — US disclosed
EP-0966424-A1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1999-12-29 — — EP disclosed
WO-1998032730-A1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 1998-07-30 — — WO disclosed
Send feedback